Excalibur Management Corp Merck & Co., Inc. Transaction History

Excalibur Management Corp

$261 Million
Q3 2024

A detailed history of Excalibur Management Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Excalibur Management Corp holds 48,138 shares of MRK stock, worth $4.79 Million. This represents 2.1% of its overall portfolio holdings.

Number of Shares

48,138

Previous 48,574 0.9%

Holding current value

$4.79 Million

Previous $6.01 Million 9.1%

% of portfolio

2.1%

Previous 2.46%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $48,461 - $56,230	-436 Reduced 0.9%	48,138 $5.47 Million
Q2 2024 Aug 09, 2024	BUY	$123.8 - $132.96 $47,910 - $51,455	387 Added 0.8%	48,574 $6.01 Million
Q1 2024 May 13, 2024	SELL	$113.24 - $131.95 $24,573 - $28,633	-217 Reduced 0.45%	48,187 $6.36 Million
Q4 2023 Feb 12, 2024	SELL	$100.18 - $109.02 $2,304 - $2,507	-23 Reduced 0.05%	48,404 $5.28 Million
Q3 2023 Nov 09, 2023	BUY	$102.95 - $114.33 $78,550 - $87,233	763 Added 1.6%	48,427 $4.99 Million
Q2 2023 Aug 08, 2023	SELL	$108.61 - $118.38 $239,376 - $260,909	-2,204 Reduced 4.42%	47,664 $5.5 Million
Q1 2023 May 05, 2023	SELL	$102.94 - $114.86 $32,426 - $36,180	-315 Reduced 0.63%	49,868 $5.31 Million
Q4 2022 Feb 10, 2023	SELL	$87.44 - $112.11 $172,781 - $221,529	-1,976 Reduced 3.79%	50,183 $5.57 Million
Q3 2022 Nov 04, 2022	SELL	$84.53 - $94.96 $360,689 - $405,194	-4,267 Reduced 7.56%	52,159 $4.49 Million
Q2 2022 Jul 25, 2022	SELL	$83.49 - $94.64 $790,984 - $896,619	-9,474 Reduced 14.38%	56,426 $5.14 Million
Q1 2022 May 03, 2022	BUY	$73.51 - $82.4 $132,538 - $148,567	1,803 Added 2.81%	65,900 $5.41 Million
Q4 2021 Feb 10, 2022	BUY	$72.28 - $90.54 $22,045 - $27,614	305 Added 0.48%	64,097 $4.91 Million
Q3 2021 Oct 28, 2021	SELL	$71.68 - $78.83 $7,454 - $8,198	-104 Reduced 0.16%	63,792 $4.79 Million
Q2 2021 Jul 26, 2021	BUY	$70.31 - $77.77 $254,803 - $281,838	3,624 Added 6.01%	63,896 $4.97 Million
Q1 2021 May 03, 2021	BUY	$68.86 - $81.11 $205,891 - $242,518	2,990 Added 5.22%	60,272 $4.65 Million
Q4 2020 Jan 26, 2021	BUY	$71.77 - $79.65 $23,899 - $26,523	333 Added 0.58%	57,282 $4.69 Million
Q3 2020 Nov 02, 2020	SELL	$73.18 - $82.95 $66,959 - $75,899	-915 Reduced 1.58%	56,949 $4.72 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $105,841 - $120,435	-1,503 Reduced 2.53%	57,864 $4.48 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $30,539 - $42,329	482 Added 0.82%	59,367 $4.57 Million
Q4 2019 Feb 04, 2020	SELL	$77.58 - $87.54 $1,396 - $1,575	-18 Reduced 0.03%	58,885 $5.36 Million
Q3 2019 Oct 21, 2019	SELL	$76.08 - $82.93 $38,040 - $41,465	-500 Reduced 0.84%	58,903 $4.96 Million
Q2 2019 Jul 26, 2019	SELL	$69.84 - $81.59 $199,183 - $232,694	-2,852 Reduced 4.58%	59,403 $4.98 Million
Q1 2019 Apr 24, 2019	SELL	$69.58 - $79.36 $147,440 - $168,163	-2,119 Reduced 3.29%	62,255 $5.18 Million
Q4 2018 Jan 29, 2019	SELL	$65.24 - $75.71 $529,944 - $614,992	-8,123 Reduced 11.2%	64,374 $4.92 Million
Q3 2018 Oct 25, 2018	SELL	$57.69 - $67.84 $830,736 - $976,896	-14,400 Reduced 16.57%	72,497 $5.14 Million
Q2 2018 Jul 26, 2018	SELL	$50.83 - $59.72 $129,311 - $151,927	-2,544 Reduced 2.84%	86,897 $5.28 Million
Q1 2018 Apr 23, 2018	BUY	$50.96 - $59.23 $325,022 - $377,768	6,378 Added 7.68%	89,441 $4.87 Million
Q4 2017 Jan 22, 2018	BUY	$51.62 - $61.64 $111,705 - $133,388	2,164 Added 2.67%	83,063 $4.67 Million
Q3 2017 Oct 25, 2017	BUY	$58.67 - $63.13 $4.75 Million - $5.11 Million	80,899	80,899 $5.18 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Excalibur Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Excalibur Management Corp with notifications on news.

Account

Excalibur Management Corp Merck & Co., Inc. Transaction History